1) Damasceno RW, Cariello AJ, Cardoso EB, et al. Upper blepharoplasty with or without resection of the orbicularis oculi muscle: a randomized double-blind left-right study. Ophthalmic Plast Reconstr Surg 2011;27:195-7.
2) Gomes JAP, Azar DT, Baudouin C, et al. TFOS DEWS II iatrogenic report. Ocul Surf 2017;15:511-38.
3) Prischmann J, Sufyan A, Ting JY, et al. Dry eye symptoms and chemosis following blepharoplasty: a 10-year retrospective review of 892 cases in a single-surgeon series. JAMA Facial Plast Surg 2013;15:39-46.
4) McKinney P, Byun M. The value of tear film breakup and Schirmer’s tests in preoperative blepharoplasty evaluation. Plast Reconstr Surg 1999 104:566-9. discussion 570-3.
5) Rees TD, LaTrenta GS. The role of the Schirmer’s test and orbital morphology in predicting dry-eye syndrome after blepharoplasty. Plast Reconstr Surg 1988;82:619-25.
6) McKinney P, Zukowski ML. The value of tear film breakup and Schirmer’s tests in preoperative blepharoplasty evaluation. Plast Reconstr Surg 1989 84:572-6. discussion 577.
7) Gilbard JP, Farris RL. Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol (Copenh) 1983;61:108-16.
9) Hamawy AH, Farkas JP, Fagien S, Rohrich RJ. Preventing and managing dry eyes after periorbital surgery: a retrospective review. Plast Reconstr Surg 2009;123:353-9.
10) Shao C, Fu Y, Lu L, et al. Dynamic changes of tear fluid after cosmetic transcutaneous lower blepharoplasty measured by optical coherence tomography. Am J Ophthalmol 2014 158:55-63. e1.
12) Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003;22:640-50.
13) Jeong IY, Park YW, Lee SS, et al. Long term follow-up results of topical 0.05% cyclosporine A in patient with dry eye. Chonnam Med J 2008;44:151-6.
14) Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 2001;108:586-92.
15) Yoon KC, Im SK, Kim HG, You IC. Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome. Cornea 2011;30:972-6.
16) Yoon KC, Heo H, Im SK, et al. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol 2007;144:86-92.
17) Tsubota K. Tear dynamics and dry eye. Prog Retin Eye Res 1998;17:565-96.
18) Kaido M, Goto E, Dogru M, Tsubota K. Punctal occlusion in the management of chronic Stevens-Johnson syndrome. Ophthalmology 2004;111:895-900.
19) Yoon KC, Jeong IY, Im SK, et al. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. Bone Marrow Transplant 2007;39:231-5.
20) Yoon KC, Im SK, Park YG, et al. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea 2006;25:268-72.
22) Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes. Eye (Lond) 1991;5(Pt 4):395-411.
23) Pflugfelder SC, Tseng SC, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 1998;17:38-56.
24) Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology 2008;115:911-5.
25) Fagien S. Reducing the incidence of dry eye symptoms after blepharoplasty. Aesthet Surg J 2004;24:464-8.
26) Whipple KM, Korn BS, Kikkawa DO. Recognizing and managing complications in blepharoplasty. Facial Plast Surg Clin North Am 2013;21:625-37.
27) Lelli GJ Jr, Lisman RD. Blepharoplasty complications. Plast Reconstr Surg 2010;125:1007-17.
28) Tseng SC. A practical treatment algorithm for managing ocular surface and tear disorders. Cornea 2011;30 Suppl 1:S8-14.
29) Wan T, Jin X, Lin L, et al. Incomplete blinking may attribute to the development of meibomian gland dysfunction. Curr Eye Res 2016;41:179-85.
31) The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:75-92.
32) Rah MJ. A review of hyaluronan and its ophthalmic applications. Optometry 2011;82:38-43.
33) Woo IH, Hong JG, Huh JA, et al. Comparison of osmolarity of various artificial tears products commercially available in South Korea. J Korean Ophthalmol Soc 2018;59:117-22.